DaVita Inc. (NYSE:DVA) Stock Holdings Reduced by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D lessened its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 11.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,333 shares of the company's stock after selling 2,196 shares during the quarter. State of New Jersey Common Pension Fund D's holdings in DaVita were worth $2,592,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Strategic Financial Concepts LLC purchased a new position in shares of DaVita in the 4th quarter worth about $9,371,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in DaVita during the 4th quarter worth approximately $597,000. Summit Trail Advisors LLC raised its stake in shares of DaVita by 9.0% during the fourth quarter. Summit Trail Advisors LLC now owns 25,416 shares of the company's stock valued at $3,801,000 after purchasing an additional 2,107 shares during the period. Wingate Wealth Advisors Inc. acquired a new position in shares of DaVita during the fourth quarter worth $82,000. Finally, Empowered Funds LLC grew its holdings in DaVita by 856.4% during the 4th quarter. Empowered Funds LLC now owns 55,698 shares of the company's stock valued at $8,330,000 after purchasing an additional 49,874 shares in the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Barclays boosted their price target on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $162.80.

DaVita Stock Performance

NYSE DVA traded down $3.59 during trading hours on Friday, hitting $142.33. The company had a trading volume of 1,605,084 shares, compared to its average volume of 845,867. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The firm has a market cap of $11.39 billion, a P/E ratio of 13.25, a price-to-earnings-growth ratio of 1.14 and a beta of 0.94. DaVita Inc. has a fifty-two week low of $120.78 and a fifty-two week high of $179.60. The business has a fifty day simple moving average of $161.24 and a 200-day simple moving average of $157.81.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.